BINEX Co., Ltd. (KOSDAQ:053030)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,560
-70 (-0.42%)
Aug 14, 2025, 3:30 PM KST
-19.81%
Market Cap 512.11B
Revenue (ttm) 140.13B
Net Income (ttm) -25.29B
Shares Out 30.92M
EPS (ttm) -806.22
PE Ratio n/a
Forward PE 47.98
Dividend n/a
Ex-Dividend Date n/a
Volume 212,023
Average Volume 319,852
Open 16,640
Previous Close 16,630
Day's Range 16,510 - 17,000
52-Week Range 12,800 - 27,300
Beta 0.86
RSI 49.58
Earnings Date Aug 13, 2025

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1957
Employees 616
Stock Exchange KOSDAQ
Ticker Symbol 053030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.